Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study

por Ballantyne, Christie M., Manku, Mehar S., Bays, Harold E., Philip, Sephy, Granowitz, Craig, Doyle, Ralph T., Juliano, Rebecca A.
Publicado 2019

EPA and DHA containing phospholipids have contrasting effects on membrane structure

por Sherratt, Samuel C.R., Juliano, Rebecca A., Copland, Christina, Bhatt, Deepak L., Libby, Peter, Mason, R. Preston
Publicado 2021

Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis

por Brinton, Eliot A., Ballantyne, Christie M., Guyton, John R., Philip, Sephy, Doyle, Ralph T., Juliano, Rebecca A., Mosca, Lori
Publicado 2018

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies

por Olshansky, Brian, Chung, Mina K, Budoff, Matthew J, Philip, Sephy, Jiao, Lixia, Doyle, Jr., Ralph T, Copland, Christina, Giaquinto, Alex, Juliano, Rebecca A, Bhatt, Deepak L
Publicado 2020

Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT

por Selvaraj, Senthil, Bhatt, Deepak L., Steg, Ph. Gabriel, Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Juliano, Rebecca A., Jiao, Lixia, Tardif, Jean‐Claude, Ballantyne, Christie M.
Publicado 2022

Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

por Bhatt, Deepak L., Steg, Ph. Gabriel, Brinton, Eliot A., Jacobson, Terry A., Miller, Michael, Tardif, Jean‐Claude, Ketchum, Steven B., Doyle, Ralph T., Murphy, Sabina A., Soni, Paresh N., Braeckman, Rene A., Juliano, Rebecca A., Ballantyne, Christie M.
Publicado 2017

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT

por Olshansky, Brian, Bhatt, Deepak L., Miller, Michael, Steg, Ph. Gabriel, Brinton, Eliot A., Jacobson, Terry A., Ketchum, Steven B., Doyle, Ralph T., Juliano, Rebecca A., Jiao, Lixia, Kowey, Peter R., Reiffel, James A., Tardif, Jean‐Claude, Ballantyne, Christie M., Chung, Mina K.
Publicado 2023

REDUCE-IT INTERIM: accumulation of data across prespecified interim analyses to final results

por Olshansky, Brian, Bhatt, Deepak L, Miller, Michael, Steg, Ph. Gabriel, Brinton, Eliot A, Jacobson, Terry A, Ketchum, Steven B, Doyle Jr, Ralph T, Juliano, Rebecca A, Jiao, Lixia, Granowitz, Craig, Tardif, Jean-Claude, Mehta, Cyrus, Mukherjee, Rajat, Ballantyne, Christie M, Chung, Mina K
Publicado 2020

Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL

por Majithia, Arjun, Bhatt, Deepak L., Friedman, Allon N., Miller, Michael, Steg, Ph. Gabriel, Brinton, Eliot A., Jacobson, Terry A., Ketchum, Steven B., Juliano, Rebecca A., Jiao, Lixia, Doyle, Ralph T., Granowitz, Craig, Budoff, Matthew, Preston Mason, R., Tardif, Jean-Claude, Boden, William E., Ballantyne, Christie M.
Publicado 2021

REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States

por Bhatt, Deepak L., Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Steg, Ph. Gabriel, Ketchum, Steven B., Doyle, Ralph T., Juliano, Rebecca A., Jiao, Lixia, Granowitz, Craig, Tardif, Jean-Claude, Olshansky, Brian, Chung, Mina K., Gibson, C. Michael, Giugliano, Robert P., Budoff, Matthew J., Ballantyne, Christie M.
Publicado 2020

Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses

por Peterson, Benjamin E., Bhatt, Deepak L., Steg, Ph. Gabriel, Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Ketchum, Steven B., Juliano, Rebecca A., Jiao, Lixia, Doyle, Ralph T., Granowitz, Craig, Gibson, C. Michael, Pinto, Duane, Giugliano, Robert P., Budoff, Matthew J., Tardif, Jean-Claude, Verma, Subodh, Ballantyne, Christie M.
Publicado 2020

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI

por Peterson, Benjamin E., Bhatt, Deepak L., Steg, Ph. Gabriel, Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Ketchum, Steven B., Juliano, Rebecca A., Jiao, Lixia, Doyle, Ralph T., Granowitz, Craig, Gibson, C. Michael, Pinto, Duane, Giugliano, Robert P., Budoff, Matthew J., Tardif, Jean‐Claude, Verma, Subodh, Ballantyne, Christie M.
Publicado 2022

A randomized trial of icosapent ethyl in ambulatory patients with COVID-19

por Kosmopoulos, Andrew, Bhatt, Deepak L., Meglis, Gus, Verma, Raj, Pan, Yi, Quan, Adrian, Teoh, Hwee, Verma, Maya, Jiao, Lixia, Wang, Robert, Juliano, Rebecca A., Kajil, Mahesh, Kosiborod, Mikhail N., Bari, Basel, Berih, Abdullahi A., Aguilar, Mallory, Escano, Antonnette, Leung, Andrew, Coelho, Idelta, Hibino, Makoto, Díaz, Rafael, Mason, R. Preston, Steg, Ph. Gabriel, Simon, Tabassome, Go, Alan S., Ambrosy, Andrew P., Choi, Richard, Kushner, Arthur M., Leiter, Lawrence A., Al-Omran, Mohammed, Verma, Subodh, Mazer, C. David
Publicado 2021